Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- News2
- Press Releases
- Stakeholder Events
- Uncategorized
- Young People with MS
EMSP Membership Newsletter: Second edition
We are very glad to present the second edition of our Membership Newsletter. With the great support of our members, we…
EMSP Membership Newsletter: Second edition
We are very glad to present the second edition of our Membership Newsletter. With the great support of our members, we…
Rehabilitation through sport. MS testimony
By Milena Trojanowska In 2015 I ran a marathon. It was almost eight years after I had my first MS…
Availability issues for approved drugs. Case study: Nabiximols
By Harriet Doig MS Ireland includes the availability and reimbursement of MS drugs among its priorities as a patient organisation….
MS physical activity platform launched online
By Sandra Fernández The patient organisation Multiple Sclerosis Spain (EME) moved its popular Platform for Promotion of Physical Activity…
MS diagnosis testimony: I feared it was cancer
By Labinot Demi My name is Labinot Demi, I live in Kosovo and I was diagnosed with multiple sclerosis in…